All posts by Sarah-Jane Dobson

International products lawyer, Cooley LLP

No chance of makeup – Brexit update for cosmetics companies in the EU and UK

Sarah-Jane Dobson
Due to some unique aspects of the EU Cosmetics Regulation compared to other EU product safety regulations, the cosmetics industry has been particularly impacted by Brexit. Given that Brexit has now taken place, it is timely to reconsider this ongoing impact on industry and provide some guidance on forward-looking planning.

The MHRA make it clear: the UK will take a backseat in EU’s medicine licensing regime post-Brexit

Sarah-Jane Dobson
On 18 February 2020, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), updated its guidance on medicine licensing post-Brexit “Apply for a licence to market a medicine in the UK”. The update provides further clarity on the UK’s status in the licensing process now that Brexit has taken place.